NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

... , I would suggest that people reread the latest patent granted Northwest. The breadth and width of that patent is very expansive and makes it very difficult for our competition to advantage their companies to our technologies.

You got to be kidding me.

The patent is specifically for a "method B DCVax-Direct" that is matured for about 16 hours (they disallowed 12-20) using a sauce that includes the BCG vaccine. It has nothing at to do with with DCVax-L.

Nobody knows if protecting Direct is worth anything. They ran a P1 trial 6 years ago. Since then nothing. The only trial on the books is another P1. And nobody knows if this would even be the best way to make a "Direct". That would be the secret sauce.